World Vaccine Congress Europe
World Vaccine Congress Europe

 

2024 Speakers

28-31 October 2024 | Barcelona

 

Sultan Abduljawad, Global Scientific Affairs Advisor, BioNTech

Sultan Abduljawad | Global Scientific Affairs Advisor | BioNTech » speaking at Vaccine Congress Europe

jeffrey Almond, Former VP Discovery R&D, Sanofi & Visiting Professor, University of Oxford - Oxford Vaccine Group

jeffrey Almond | Former VP Discovery R&D, Sanofi & Visiting Professor | University of Oxford - Oxford Vaccine Group » speaking at Vaccine Congress Europe

Galit Alter, VP of Immunology Research, Moderna

Galit Alter | VP of Immunology Research | Moderna » speaking at Vaccine Congress Europe

William Ampofo, Executive Director, African Vaccine Manufacturing Initiative

William Ampofo | Executive Director | African Vaccine Manufacturing Initiative » speaking at Vaccine Congress Europe

Montserrat Arroyo, Deputy Director General for International Standards and Science, WOAH

Montserrat Arroyo | Deputy Director General for International Standards and Science | WOAH » speaking at Vaccine Congress Europe

Francesco Berlanda Scorza, Director GVGH, GSK Vaccines for Global Health (GVGH)

Francesco Berlanda Scorza | Director GVGH | GSK Vaccines for Global Health (GVGH) » speaking at Vaccine Congress Europe

Marta Blay, Sr. Project Manager, PPD

Ulf Niklas BLOMBERG, Executive Director, Innovative Health Initiative

Cedric Bogaert, Chief Executive Officer, MYNEO NV

Maria Elena Bottazzi, Co-Director of Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine

Gabrielle Breugelmans, Head of Epidemiology, CEPI

Gabrielle Breugelmans | Head of Epidemiology | CEPI » speaking at Vaccine Congress Europe

Luigi Buonaguro, Lab Director, Istituto Nazionale Tumori "Pascale"

Nicolas Burdin, Global Head of R&D, Clover Pharma

Chris Bussineau, Senior Consultant, Biologics Consulting Group, Inc.

Maya Cabot, Senior Product Manager, Integral Molecular

Michael Caldwell, Assoc VP Vaccine Research & Education, Meharry Medical College

Miles Carroll, Head of High Consequence Emerging Viruses Group, Pandemic Sciences Institute, University of Oxford

Miles Carroll | Head of High Consequence Emerging Viruses Group, Pandemic Sciences Institute | University of Oxford » speaking at Vaccine Congress Europe

Juliana Cassataro, Professor, University of San Martin

Andrew Catchpole, CSO, hVIVO

Marco Cavaleri, Head of Biological Health Threats and Vaccines Strategy, European medicines agency

Marco Cavaleri | Head of Biological Health Threats and Vaccines Strategy | European medicines agency » speaking at Vaccine Congress Europe

Ajoy Chakrabarti, Portfolio And Platform Lead, The Bill & Melinda Gates Foundation

Ajoy Chakrabarti | Portfolio And Platform Lead | The Bill & Melinda Gates Foundation » speaking at Vaccine Congress Europe

Valerie Chambard, Supply Chain Lead, CEPI

Valerie Chambard | Supply Chain Lead | CEPI » speaking at Vaccine Congress Europe

Roman Chicz, Global Head Of External Research And Development, Sanofi

Roman Chicz | Global Head Of External Research And Development | Sanofi » speaking at Vaccine Congress Europe

Dennis Christensen, Head of Global R&D, Croda

Margherita Coccia, Director, GSK

Nicolas Collin, Co-Founder and Chief Executive Officer, Vaccine Formulation Institute CH Ltd

Nicolas Collin | Co-Founder and Chief Executive Officer | Vaccine Formulation Institute CH Ltd » speaking at Vaccine Congress Europe

Tim Cooke, CEO, Omniose

Chad Costley, Chief Executive Officer, BlueWillow Biologics, Inc.

Jakob Cramer, Head Of Clinical Development, CEPI

Jakob Cramer | Head Of Clinical Development | CEPI » speaking at Vaccine Congress Europe

James Cummings, Chief Medical Officer, Vaxart

Christine Dahlke, Translational Immunology Lead, CEPI

Christine Dahlke | Translational Immunology Lead | CEPI » speaking at Vaccine Congress Europe

Wian de Jongh, Chief Executive Officer, adaptvac

Ingrid de Visser-Kamerling, Associate Research Director, Stichting Centre for Human Drug Research

Antu Dey, Senior Vice President, Preclinical R&D, Icosavax, Inc

Antu Dey | Senior Vice President, Preclinical R&D | Icosavax, Inc » speaking at Vaccine Congress Europe

Kyle Doolan, Director of Research, Integral Molecular

Helge Dorfmuller, Principal Investigator, University of Dundee

Helge Dorfmuller | Principal Investigator | University of Dundee » speaking at Vaccine Congress Europe

Mark Emalfarb, Chief Executive Officer, Dyadic International Inc

Jaime Espin, Professor, Andalusian School Of Public Health

Nicola Esposito, QC Molecular Biology Assays Manager, Advaxia Biologics

Aaron Esser-Kahn, Professor, University of Chicago

Jay Evans, Chief Scientific and Strategy Officer, Inimmune

Katie Ewer, Senior Project Leader, GSK

Daniel Faissol, Principal Investigator, Center for Bioengineering, Executive Director, Predictive Design of Biologics, Lawrence Livermore National Laboratory

Ricarda Finnern, Chief Scientific Officer, LenioBio GmBH

Martin Friede, Coordinator, Initiative For Vaccine Research Immunization, Vaccines And Biologicals Department, World Health Organisation

Antonio Garcia Maldonado, Investment Professional, Strategic Investment Fund, Bill and Melinda Gates Foundation

Cyril Gay, Senior National Program Leader, A.R.S. National Programs

Cyril Gay | Senior National Program Leader | A.R.S. National Programs » speaking at Vaccine Congress Europe

Markus Gerhard, Prof. of Medical Microbiology and Immunology, Technical University Munich

Markus Gerhard | Prof. of Medical Microbiology and Immunology | Technical University Munich » speaking at Vaccine Congress Europe

Paul Gillard, VP, Medical Science & Strategy, PPD, part of Thermo Fisher Scientific

Trang Gisler, Senior Director, Government and Public Health Services, PPD, part of Thermo Fisher Scientific

Brianna Goodale, Head of Data Science, Julius Clinical

Marion Gruber, Vice President of Public Health and Regulatory Affairs, IAVI

Andrea Guerra, Regional Clinical Director Vaccines - Europe, MSD

Andrea Guerra | Regional Clinical Director Vaccines - Europe | MSD » speaking at Vaccine Congress Europe

Swati Gupta, VP, Head of Emerging Infectious Diseases and Epidemiology, International AIDS Vaccine Initiative

Bassam Hallis, Deputy Director, Research and Evaluation, UK Health Security Agency

Bassam Hallis | Deputy Director, Research and Evaluation | UK Health Security Agency » speaking at Vaccine Congress Europe

Ali M Harandi, Lab Head, Dpt Of Microbiology And Immunology, University of Gothenburg

Mateusz Hasso-Agopsowicz, Technical Officer, World Health Organization

Mateusz Hasso-Agopsowicz | Technical Officer | World Health Organization » speaking at Vaccine Congress Europe

Ana Maria Henao-Restrepo, Co-Lead R&D Blueprint for epidemics, Health Emergencies Programme (WHE),, World Health Organisation

Ana Maria Henao-Restrepo | Co-Lead R&D Blueprint for epidemics, Health Emergencies Programme (WHE), | World Health Organisation » speaking at Vaccine Congress Europe

Jennifer Hendriks, Head Biomarkers and Clinical Immunology, Janssen Vaccines & Prevention B.V.

Jennifer Hendriks | Head Biomarkers and Clinical Immunology | Janssen Vaccines & Prevention B.V. » speaking at Vaccine Congress Europe

Mark Howarth, Sheild Chair of Pharmacology, University Of Cambridge

Munir Iqbal, Head of the Avian Influenza Virus (AIV), The Pirbright Institute

Emilie Karafillakis, European Director, Vaccine Confidence Project, London School of Hygiene and Tropical Medicine

Nektaria Karavas, Business Development, Aptar

Hans Keirstead, Chief Executive Officer, AIVITA Biomedical, Inc.

Edward Kelley, Chief Global Health Officer, ApiJect

Jerome Kim, Director General, IVI

Jerome Kim | Director General | IVI » speaking at Vaccine Congress Europe

Michael Kowarik, cso, LimmaTech Biologics AG

Gemma Lahuerta, Parenteral Development Director, LABORATORIO REIG JOFRE, S.A.

Gemma Lahuerta | Parenteral Development Director | LABORATORIO REIG JOFRE, S.A. » speaking at Vaccine Congress Europe

Teresa Lambe, Calleva Head of Vaccine Immunology & Professor of Vaccinology & Immunology, University of Oxford

Alexandre Le Vert, Chief Executive Officer, Osivax

Geert Leroux Roels, Professor Emeritus, Gent University

Ofer Levy, Director, Precision Vaccines Program, Boston Children's Hospital

Andreea Lordache, Manager, Science & Regulatory Affairs, Vaccines Europe

Andreea Lordache | Manager, Science & Regulatory Affairs | Vaccines Europe » speaking at Vaccine Congress Europe

Marie-Louise Lunn, Global Product Manager, Strategic Marketing, Novo Nordisk Pharmatech

Irina Meln, Sr Innovation Manager, European Vaccine Initiative

Lenny Moise, VP, Research, SeromYx

Anne Moore, NIBRT PI, University Colleague Cork

Irene Nkumama, Malaria Programme Manager, European Vaccine Initiative (EVI)

Hanna Nohynek, Chief Physician, National Institute for Health and Welfare

Isabel Oliver, Director General of Science & Research and Chief Scientific Officer, UK Health Security Agency

Isabel Oliver | Director General of Science & Research and Chief Scientific Officer | UK Health Security Agency » speaking at Vaccine Congress Europe

Ab Osterhaus, Director of Research Center For Emerging Infections and Zoonoses and Professor, University of Veterinary Medicine Hannover

Ab Osterhaus | Director of Research Center For Emerging Infections and Zoonoses and Professor | University of Veterinary Medicine Hannover » speaking at Vaccine Congress Europe

Serge Pampfer, Chief Executive Officer, LoValtech

Serge Pampfer | Chief Executive Officer | LoValtech » speaking at Vaccine Congress Europe

Francesco Pappalardo, Deputy Director, Department of Drug and Health Sciences, University of Catania

Robert Paris, VP, Therapeutic Area Head, Latent Viruses, Moderna

Karina Pasquevich, Researcher, UNSAM

Karina Pasquevich | Researcher | UNSAM » speaking at Vaccine Congress Europe

Shanti Pather, Senior Global Medical Affairs Director, Vaccines, BioNTech SE

Tim Peterson, Associate Director, Product and Process Development, Kindeva Drug Delivery

Haiko Pillu, Director Operations CPU, SGS

Jan Poolman, Head Bacterial Vaccine Discovery and Early Development, Janssen

Jan Poolman | Head Bacterial Vaccine Discovery and Early Development | Janssen » speaking at Vaccine Congress Europe

Mukul Pore, Executive Director, Intox Pvt Ltd

Marco Pravetoni, Center Director & Rick L. Seaver Endowed Professor of Psychiatry, University of Washington School of Medicine

Sibilia Quilici, Executive Director, Vaccines Europe

Ruben Rizzi, SVP Global Regulatory Affairs, BioNTech SE

Cesar Sanz Rodriguez, Vice President, Medical Affairs - Europe, Middle East & Africa, Moderna

Cesar Sanz Rodriguez | Vice President, Medical Affairs - Europe, Middle East & Africa | Moderna » speaking at Vaccine Congress Europe

Simona Rondini, Head Bacterial Projects and Senior Project Leader, GSK Vaccines

Simona Rondini | Head Bacterial Projects and Senior Project Leader | GSK Vaccines » speaking at Vaccine Congress Europe

Birgitte Rønø, Chief Scientific Officer, Evaxion Biotech A/S

Jerald Sadoff, Chief Medical Officer, Centivax

Jeremy Salt, Chief Executive Officer, The Vaccine Group

Avencia Sánchez-Mejías García, Chief Executive Officer, Integra Therapeutics

Gautam Sanyal, Principal Consultant, Vaccine Analytics, LLC, USA

Melanie Saville, Chief Scientific Officer, PATH

Taylor Sexton, Executive Director, Medical Countermeasures Coaltion

Amy Shurtleff, Head of Animal Models, CEPI

Joe Smyser, Chief Executive Officer, PGP (The Public Good Projects)

Matthew Snape, VP, Clinical Development, Paediatric and Maternal Vaccines & Visiting Professor, Department of Paediatrics, University of Oxford, Moderna

Matthew Snape | VP, Clinical Development, Paediatric and Maternal Vaccines & Visiting Professor, Department of Paediatrics, University of Oxford | Moderna » speaking at Vaccine Congress Europe

Tom Solomon, Director, The Pandemic Institute

Walter Straus, Vice President, Clinical Safety & Risk Management, Moderna Therapeutics

Miriam Sturkenboom, Professor in Real World Evidence and Head of the department of DataScience and Biostatistics, University Medical Center Utrecht

Miriam Sturkenboom | Professor in Real World Evidence and Head of the department of DataScience and Biostatistics | University Medical Center Utrecht » speaking at Vaccine Congress Europe

Julie Suman, Vice President, Scientific Affairs, Aptar Pharma

Mojca Tajnik Sbaizero, Head of Product-Application Area, Process Development Dept. for Viral Vectors and Vaccines, Sartorius BIA Separations

Andrea Tattersall, Director Lab Operations, Revvity

Nigel Temperton, Professor and Director, University of Kent

Petro Terblanche, Chief Executive Officer, Afrigen Biologics (Pty) Ltd

Angus Thomson, Principal, Irimi

Angus Thomson | Principal | Irimi » speaking at Vaccine Congress Europe

Thomas Trolle, Bioinformatics Specialist, Evaxion Biotech

Sean Tucker, CSO, Vaxart

Sean Tucker | CSO | Vaxart » speaking at Vaccine Congress Europe

Satoshi Uchida, Professor, Tokyo Medical and Dental University (TMDU)

Sebastian Ulbert, Deputy Director, Fraunhofer-Institute for Cell Therapy and Immunology

Nico Vandaele, Prof. dr., KU Leuven, Access-To-Medicines Research Centre

Joris Vandeputte, Past President, IABS

Joris Vandeputte | Past President | IABS » speaking at Vaccine Congress Europe

Charlotte Vernhes, Director, Scientific and Medical Affairs, Vaccines Europe

Carla Vinals, VP Head of Regulatory Strategy, Moderna

Carla Vinals | VP Head of Regulatory Strategy | Moderna » speaking at Vaccine Congress Europe

Thomas Waite, Deputy Chief Medical Officer, UK Department of Health

Daniel Wolfe, Deputy Direct, BARDA CBRN Medical Countermeasures, Biomedical Advanced Research And Development Authority

Roland Zahn, Senior Scientific Director - Head Preclinical Immunology - Viral Vaccines, Johnson & Johnson

Tal Zaks, Partner, Private Equity, Orbimed